Literature DB >> 27538373

Reflections on MUC1 glycoprotein: the hidden potential of isoforms in carcinogenesis.

Andreia M Sousa1,2, Paul M Grandgenett3, Leonor David4,5,6, Raquel Almeida4,5,6,7, Michael Anthony Hollingsworth3, Filipe Santos-Silva4,5,6.   

Abstract

Mucin 1 (MUC1) has been described as the renaissance molecule due to the large set of functions it displays in both normal and neoplastic cells. This membrane-tethered glycoprotein is overexpressed and aberrantly glycosylated in most epithelial cancers, being involved in several processes related with malignant phenotype acquisition. With a highly polymorphic structure, both in the polypeptide and glycan counterparts, MUC1 variability has been associated with susceptibility to several diseases, including cancer. Biochemical features and biological functions have been characterized upon the full-length MUC1 protein, remaining to clarify the real impact on cell dynamics of the plethora of MUC1 isoforms. This review aims to encompass a detailed characterization of MUC1 role in carcinogenesis, highlighting recent findings in cell differentiation and uncovering new evidences of MUC1 isoforms involvement in malignant phenotype.
© 2016 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MUC1; MUC1 splice variants; cancer; cell differentiation

Mesh:

Substances:

Year:  2016        PMID: 27538373     DOI: 10.1111/apm.12587

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  6 in total

1.  Untouchable genes in the human genome: Identifying ideal targets for cancer treatment.

Authors:  Ivan P Gorlov; Olga Y Gorlova; Christopher I Amos
Journal:  Cancer Genet       Date:  2019-01-24

2.  MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells.

Authors:  Tian-Qiao Huang; Ya-Nan Bi; Zheng Cui; Jin-Ping Guan; Yi-Chuan Huang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 3.  Exploiting poly(I:C) to induce cancer cell apoptosis.

Authors:  Francesca Bianchi; Samantha Pretto; Elda Tagliabue; Andrea Balsari; Lucia Sfondrini
Journal:  Cancer Biol Ther       Date:  2017-09-07       Impact factor: 4.742

4.  CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity.

Authors:  Jing Jie; Yixin Zhang; Hongyue Zhou; Xiaoyu Zhai; Nannan Zhang; Hongyan Yuan; Weihua Ni; Guixiang Tai
Journal:  Int J Mol Sci       Date:  2018-03-20       Impact factor: 5.923

5.  Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes.

Authors:  Miguel Aco-Tlachi; Ricardo Carreño-López; Patricia L Martínez-Morales; Paola Maycotte; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez; Gerardo Santos-López; Julio Reyes-Leyva; Verónica Vallejo-Ruiz
Journal:  Infect Agent Cancer       Date:  2018-07-20       Impact factor: 2.965

6.  Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana.

Authors:  E Atta Manu; K Bedu-Addo; N A Titiloye; C Ameh-Mensah; F Opoku; B M Duduyemi
Journal:  J Oncol       Date:  2020-04-22       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.